Yuelong Jiang, Long Liu, Yirong Jiang, Zhifeng Li, Liying Feng, Xinguo Zhuang, . . . Bing Xu. (2022). Preclinical Evaluation of the Multiple Tyrosine Kinases Inhibitor Anlotinib in Leukemia Stem Cells. MDPI AG.
Chicago Style (17th ed.) CitationYuelong Jiang, et al. Preclinical Evaluation of the Multiple Tyrosine Kinases Inhibitor Anlotinib in Leukemia Stem Cells. MDPI AG, 2022.
MLA (9th ed.) CitationYuelong Jiang, et al. Preclinical Evaluation of the Multiple Tyrosine Kinases Inhibitor Anlotinib in Leukemia Stem Cells. MDPI AG, 2022.
Warning: These citations may not always be 100% accurate.